Cargando…
Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis
BACKGROUND: The proportion of incident cases of HPV-attributable cancers is highest in the low- and middle-income countries (LMICs) but many are yet to initiate HPV vaccination programs. This meta-analysis was performed to assess the uptake of HPV vaccination in LMICs at the beginning of the global...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102703/ https://www.ncbi.nlm.nih.gov/pubmed/33997733 http://dx.doi.org/10.1016/j.eclinm.2021.100836 |
_version_ | 1783689157931958272 |
---|---|
author | Dorji, Thinley Nopsopon, Tanawin Tamang, Saran Tenzin Pongpirul, Krit |
author_facet | Dorji, Thinley Nopsopon, Tanawin Tamang, Saran Tenzin Pongpirul, Krit |
author_sort | Dorji, Thinley |
collection | PubMed |
description | BACKGROUND: The proportion of incident cases of HPV-attributable cancers is highest in the low- and middle-income countries (LMICs) but many are yet to initiate HPV vaccination programs. This meta-analysis was performed to assess the uptake of HPV vaccination in LMICs at the beginning of the global strategy to eliminate cervical cancer and describes the gaps and challenges. METHODS: A systematic search was conducted in PubMed, EMBASE, Scopus, Web of Science, and CENTRAL databases for observational studies that reported the uptake of HPV vaccination until October 2020. The meta-analysis was done using a random-effects model to assess the pooled estimate of HPV uptake. CRD42021218429 FINDINGS: During 2008–2020, an estimated 3.3 million females received at least one dose of HPV vaccine with 61.69% of the target population vaccinated. In countries with high uptake, the pooled estimate of uptake was higher in females than males (45.48% vs 8.45%) and showed significant decline in 2015–2020 compared to 2006–2014 (89.03% vs 41.48%). In countries with low uptake, the estimate of uptake was low in both males and females (5.31% vs 2.93%) and showed increase in uptake in 2015–2020 compared to 2006–2014 (0.76% vs 5.22%). In countries with high uptake, compared to routine programs, the estimate was higher when delivered through demonstration programs (89.94% vs 59.74%). INTERPRETATION: The major concern was a significant drop in the uptake in countries that started with high uptake, challenges in the maintenance of vaccine uptake, sustainability of funding and the lack of standard monitoring and reporting. |
format | Online Article Text |
id | pubmed-8102703 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-81027032021-05-14 Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis Dorji, Thinley Nopsopon, Tanawin Tamang, Saran Tenzin Pongpirul, Krit EClinicalMedicine Research Paper BACKGROUND: The proportion of incident cases of HPV-attributable cancers is highest in the low- and middle-income countries (LMICs) but many are yet to initiate HPV vaccination programs. This meta-analysis was performed to assess the uptake of HPV vaccination in LMICs at the beginning of the global strategy to eliminate cervical cancer and describes the gaps and challenges. METHODS: A systematic search was conducted in PubMed, EMBASE, Scopus, Web of Science, and CENTRAL databases for observational studies that reported the uptake of HPV vaccination until October 2020. The meta-analysis was done using a random-effects model to assess the pooled estimate of HPV uptake. CRD42021218429 FINDINGS: During 2008–2020, an estimated 3.3 million females received at least one dose of HPV vaccine with 61.69% of the target population vaccinated. In countries with high uptake, the pooled estimate of uptake was higher in females than males (45.48% vs 8.45%) and showed significant decline in 2015–2020 compared to 2006–2014 (89.03% vs 41.48%). In countries with low uptake, the estimate of uptake was low in both males and females (5.31% vs 2.93%) and showed increase in uptake in 2015–2020 compared to 2006–2014 (0.76% vs 5.22%). In countries with high uptake, compared to routine programs, the estimate was higher when delivered through demonstration programs (89.94% vs 59.74%). INTERPRETATION: The major concern was a significant drop in the uptake in countries that started with high uptake, challenges in the maintenance of vaccine uptake, sustainability of funding and the lack of standard monitoring and reporting. Elsevier 2021-04-17 /pmc/articles/PMC8102703/ /pubmed/33997733 http://dx.doi.org/10.1016/j.eclinm.2021.100836 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Paper Dorji, Thinley Nopsopon, Tanawin Tamang, Saran Tenzin Pongpirul, Krit Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis |
title | Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis |
title_full | Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis |
title_fullStr | Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis |
title_full_unstemmed | Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis |
title_short | Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis |
title_sort | human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102703/ https://www.ncbi.nlm.nih.gov/pubmed/33997733 http://dx.doi.org/10.1016/j.eclinm.2021.100836 |
work_keys_str_mv | AT dorjithinley humanpapillomavirusvaccinationuptakeinlowandmiddleincomecountriesametaanalysis AT nopsopontanawin humanpapillomavirusvaccinationuptakeinlowandmiddleincomecountriesametaanalysis AT tamangsarantenzin humanpapillomavirusvaccinationuptakeinlowandmiddleincomecountriesametaanalysis AT pongpirulkrit humanpapillomavirusvaccinationuptakeinlowandmiddleincomecountriesametaanalysis |